Susan Laura Smith - 05 Mar 2024 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Signature
/s/ John LaRocca, Attorney-in-Fact
Issuer symbol
YMAB
Transactions as of
05 Mar 2024
Net transactions value
-$27,837
Form type
4
Filing time
07 Mar 2024, 16:59:59 UTC
Previous filing
22 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Sale $27,837 -1,682 -4.7% $16.55 33,918 05 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Nondiscretionary sale to cover tax liability associated with the vesting and settlement of restricted stock units.